ArticleWorld journal of diabetes2022

Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!

Awadhesh Kumar Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.